Regulatory & Compliance

Fort Wayne Medical Settles 2024 Data Breach Lawsuit
Management & Regulatory Fort Wayne Medical Settles 2024 Data Breach Lawsuit

Documentation such as bank statements or receipts is required for those seeking to recover up to $500 in ordinary expenses related to credit monitoring and identity fees. This requirement stems from the final resolution of a class-action lawsuit against the Fort Wayne Medical Education Program

Industry Leaders Urge FDA to Expand Prior Knowledge Guidance
Research & Development Industry Leaders Urge FDA to Expand Prior Knowledge Guidance

Industry groups are requesting concrete examples of how prior clinical data can be used to optimize dosing and streamline trial designs for rare disease therapies. This collective push follows the release of the Food and Drug Administration's draft guidance concerning the use of prior knowledge in

Why Is the FTC Suing Hims & Hers Over Patient Privacy?
Management & Regulatory Why Is the FTC Suing Hims & Hers Over Patient Privacy?

The FTC's complaint details how users were allegedly billed for prescription subscriptions almost instantly, often before a licensed healthcare professional had even reviewed their medical intake forms. This aggressive legal action, filed in July 2026, represents a coordinated effort by the Federal

Kylo-11 siRNA Results Set New Standard for Heart Disease Trials
Research & Development Kylo-11 siRNA Results Set New Standard for Heart Disease Trials

Regulatory bodies like the FDA will likely demand more detailed pharmacokinetic characterization of tissue distribution following the prolonged activity seen with Kylo-11. The cardiovascular research community is currently absorbing the profound implications of the Phase 1 clinical trial results

Is India Prepared for the Evolving Threat of Bioterrorism?
Management & Regulatory Is India Prepared for the Evolving Threat of Bioterrorism?

Although India maintains a robust network of over 150 viral research laboratories, the architecture is primarily designed for public health rather than forensic attribution. This distinction is becoming increasingly vital as the national security landscape shifts away from large-scale insurgencies

How Will Fortrea’s Latest Acquisition Impact Your Clinical Trials?
Management & Regulatory How Will Fortrea’s Latest Acquisition Impact Your Clinical Trials?

Phase I Pharmacokinetic studies cannot reach their primary endpoints until bioanalytical data is confirmed as valid across the newly integrated organizational framework. The clinical research landscape shifted significantly with the announcement of Fortrea’s acquisition of Worldwide Clinical

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later